Combining dronabinol and hydromorphone in the laboratory

Plain Language Summary

Key Points & Implications

Author(s) & Affiliation(s)

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Full Citation

Dunn, Kelly E., et al. “Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the Cannabinoid Dronabinol and the opioid hydromorphone in a human laboratory pain model.” Neuropsychopharmacology, vol. 46, no. 8, 20 Apr. 2021, pp. 1451–1459, https://doi.org/10.1038/s41386-021-01007-4.

Full Paper Title:

Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model

DOI:

Published:

10.1038/s41386-021-01007-4

20. Apr. 2021

In:

Neuropsychopharmacology

Inline Citation

(Dunn et al. 2021)